Promino Nutritional Sciences Inc

OTC: MUSLF · Healthcare · Medical - Pharmaceuticals

Canadian filerHQ Burlington, ONReports USD

#817 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

29D

FH 25DQ —GM 44SS 27

v0.1 · 45/100 weight · provisional

↑ 3-yr revenue growth, Piotroski F · ↓ balance-sheet leverage, return on assets

Methodology →

Revenue TTM

$1.5M

Rev growth YoY (TTM)

+195.2%

Net income (FY)

-$2.1M

Employees

Market cap

$3.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.5M2.2M CAD2025

Net income-$2.1M-3.0M CAD2025

Operating income-$2.1M-3.0M CAD2025

Total assets$147.3k202.0k CAD2025

Liabilities$5.9M8.1M CAD2025

Equity-$5.8M-7.9M CAD2025

Revenue trend

FY2020 – FY2025 · USD

$730.2k

FY20

$1.9M

FY21

$3.1M

FY22

$1.5M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Promino Nutritional Sciences Inc booked $1.5M in FY2025 revenue, contracting 50% year over year — slower than 82% of Healthcare companies we track, at a -139.1% net margin.

Peers · Healthcare

QHSLab, Inc.69B MetaVia Inc.——Eco-Growth Strategies Inc.——OMID Holdings, Inc.48D

Key facts

CEOVito Sanzone

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersBurlington, ON

ExchangeOTC: MUSLF

Employees9

IPO date2021-10-25

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.